| Model Number |
ONYXNG35026UX |
| Medical Device Problem Codes |
Activation, Positioning or Separation Problem (2906); Positioning Problem (3009)
|
| Health Effect - Clinical Code |
No Clinical Signs, Symptoms or Conditions (4582)
|
| Date of Event |
03/08/2025
|
|
Type of Reportable Event
|
Malfunction
|
|
Additional Manufacturer Narrative
|
|
Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
| |
|
Event or Problem Description
|
|
It was reported that during use of one onyx frontier drug eluting stent, the balloon would not inflate inside the stent.An attempt was made to deploy the stent.The device was inspected prior to use and post removal of the protective sheath with no issues noted.There were no difficulties noted when removing the protective sheath and there were no difficulties noted when removing the device from the hoop.No patient injury was reported.
|
| |
|
Additional Manufacturer Narrative
|
|
Additional information: it was later clarified that no attempt was made to deploy the stent, and the issue was that the stent could not be delivered.The stent failed to cross the lesion.There were no deployment or balloon issues.Some resistance was noted while advancing the device to the lesion.Excessive force was not used.The procedure was completed.Correction: the patient was discharged home.Initial reporter name and phone number updated.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
| |
|
Additional Manufacturer Narrative
|
|
Additional information: annex d code.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
| |
|
Search Alerts/Recalls
|